Home LiteratureArticle Details
PMID: 17355862 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Glycoprotein structural genomics: solving the glycosylation problem.

Structure (London, England : 1993) ·Vol. 15 ·No. 3 ·2007-03-00 ·Pages 267-73

Chang VT, Crispin M, Aricescu AR, Harvey DJ, Nettleship JE, Fennelly JA, Yu C, Boles KS, Evans EJ, Stuart DI, Dwek RA, Jones EY, Owens RJ, Davis SJ

Abstract

Glycoproteins present special problems for structural genomic analysis because they often require glycosylation in order to fold correctly, whereas their chemical and conformational heterogeneity generally inhibits crystallization. We show that the "glycosylation problem" can be solved by expressing glycoproteins transiently in mammalian cells in the presence of the N-glycosylation processing inhibitors, kifunensine or swainsonine. This allows the correct folding of the glycoproteins, but leaves them sensitive to enzymes, such as endoglycosidase H, that reduce the N-glycans to single residues, enhancing crystallization. Since the scalability of transient mammalian expression is now comparable to that of bacterial systems, this approach should relieve one of the major bottlenecks in structural genomic analysis.

MeSH Terms
Alkaloids/chemistry,genetics,metabolism Cell Line Cloning, Molecular Enzyme Inhibitors Genomics/methods Glycoproteins/antagonists & inhibitors,chemistry,genetics,metabolism Glycosylation/drug effects Humans Swainsonine/chemistry,metabolism
Chemicals
Alkaloids Enzyme Inhibitors Glycoproteins kifunensine Swainsonine
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Chang Veronica T
Nuffield Department of Clinical Medicine and MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Crispin Max
Aricescu A Radu
Harvey David J
Nettleship Joanne E
Fennelly Janet A
Yu Chao
Boles Kent S
Evans Edward J
Stuart David I
Dwek Raymond A
Jones E Yvonne
Owens Raymond J
Davis Simon J
References (41)
41 references, click to expand
  1. N-Glycan processing by a lepidopteran insect alpha1,2-mannosidase.
    Glycobiology. 2000 Apr;10(4):347-55 PMID: 10764822
  2. Analysis of variable N-glycosylation site occupancy in glycoproteins by liquid chromatography electrospray ionization mass spectrometry.
    Anal Biochem. 2007 Feb 1;361(1):149-51 PMID: 17178093
  3. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.
    Nucleic Acids Res. 2002 Jan 15;30(2):E9 PMID: 11788735
  4. A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion.
    Biochem J. 2002 Feb 1;361(Pt 3):431-6 PMID: 11802771
  5. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24 PMID: 12370423
  6. N-linked oligosaccharide processing, but not association with calnexin/calreticulin is highly correlated with endoplasmic reticulum-associated degradation of antithrombin Glu313-deleted mutant.
    Arch Biochem Biophys. 2003 Mar 15;411(2):235-42 PMID: 12623072
  7. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding.
    Glycobiology. 2004 Feb;14(2):103-14 PMID: 14514716
  8. Gene transfer with modified polyethylenimines.
    J Gene Med. 2004 Feb;6 Suppl 1:S3-10 PMID: 14978746
  9. Structures and technology for biologists.
    Nat Struct Mol Biol. 2004 Apr;11(4):296-7 PMID: 15048099
  10. Structure of mouse Golgi alpha-mannosidase IA reveals the molecular basis for substrate specificity among class 1 (family 47 glycosylhydrolase) alpha1,2-mannosidases.
    J Biol Chem. 2004 Jul 9;279(28):29774-86 PMID: 15102839
  11. Effect of swainsonine on the processing of the asparagine-linked carbohydrate chains of alpha 1-antitrypsin in rat hepatocytes. Evidence for the formation of hybrid oligosaccharides.
    J Biol Chem. 1983 Mar 25;258(6):4032-6 PMID: 6403522
  12. High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants.
    J Biol Chem. 1990 Jun 25;265(18):10410-8 PMID: 2113054
  13. Demonstration that Golgi endo-alpha-D-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins.
    J Biol Chem. 1990 Aug 5;265(22):13104-12 PMID: 2165493
  14. Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
    J Biol Chem. 1990 Sep 15;265(26):15599-605 PMID: 2144287
  15. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48.
    J Immunol. 1991 Apr 1;146(7):2192-200 PMID: 1848579
  16. Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution.
    Cell. 1992 Mar 20;68(6):1145-62 PMID: 1547508
  17. Characterization of the endomannosidase pathway for the processing of N-linked oligosaccharides in glucosidase II-deficient and parent mouse lymphoma cells.
    J Biol Chem. 1992 Apr 25;267(12):8443-51 PMID: 1533222
  18. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2.
    Protein Eng. 1993 Feb;6(2):229-32 PMID: 8097313
  19. Characterization of endomannosidase inhibitors and evaluation of their effect on N-linked oligosaccharide processing during glycoprotein biosynthesis.
    J Biol Chem. 1993 May 5;268(13):9927-35 PMID: 8486671
  20. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase.
    J Biol Chem. 1993 Aug 5;268(22):16101-4 PMID: 8393854
  21. Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent.
    J Biol Chem. 1995 Jan 6;270(1):369-75 PMID: 7529232
  22. Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1).
    J Biol Chem. 1999 Feb 12;274(7):4115-23 PMID: 9933605
  23. Evolutionary considerations in relating oligosaccharide diversity to biological function.
    Glycobiology. 1999 Aug;9(8):747-55 PMID: 10406840
  24. Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization.
    Protein Sci. 1999 Aug;8(8):1696-701 PMID: 10452614
  25. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites.
    Glycobiology. 2005 Feb;15(2):153-64 PMID: 15385431
  26. Protein crystallization: virtual screening and optimization.
    Prog Biophys Mol Biol. 2005 Jul;88(3):285-309 PMID: 15652246
  27. Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells.
    J Immunol Methods. 2005 Mar;298(1-2):93-104 PMID: 15847800
  28. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization.
    Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):651-7 PMID: 15930615
  29. Optimisation and evaluation of a high-throughput mammalian protein expression system.
    Protein Expr Purif. 2005 Jul;42(1):111-21 PMID: 15939296
  30. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry.
    Expert Rev Proteomics. 2005 Jan;2(1):87-101 PMID: 15966855
  31. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.
    Science. 2005 Jul 22;309(5734):581-5 PMID: 15961631
  32. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins.
    Bioinformatics. 2005 Aug 15;21(16):3369-76 PMID: 15947016
  33. Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy.
    Acta Crystallogr D Biol Crystallogr. 2005 Oct;61(Pt 10):1426-31 PMID: 16204897
  34. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production.
    J Struct Funct Genomics. 2005;6(2-3):165-70 PMID: 16211514
  35. Polyethylenimine (PEI).
    Adv Genet. 2005;53:217-30 PMID: 16240995
  36. The impact of structural genomics: expectations and outcomes.
    Science. 2006 Jan 20;311(5759):347-51 PMID: 16424331
  37. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion.
    EMBO J. 2006 Feb 22;25(4):701-12 PMID: 16456543
  38. Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.
    Glycobiology. 2006 Aug;16(8):748-56 PMID: 16672288
  39. Eukaryotic expression: developments for structural proteomics.
    Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1114-24 PMID: 17001089
  40. A time- and cost-efficient system for high-level protein production in mammalian cells.
    Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50 PMID: 17001101
  41. Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells.
    EMBO J. 2001 Jun 15;20(12):3008-17 PMID: 11406577
Article Info
Journal
Structure (London, England : 1993)
Abbr.
Structure
ISSN
0969-2126
Published
2007-03-00
Pages
267-73
Language
English
Region
United States
NLM ID
101087697
PMCID
PMC1885966
Subset
IM
Grants
Wellcome Trust · 081894 · United Kingdom
Medical Research Council · G0400717 · United Kingdom
Medical Research Council · G9900061 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com